July 14 Generic drugmaker Mylan Inc said it would buy Abbott Laboratories' specialty and branded generics business outside the United States in an all-stock transaction valued at about $5.3 billion.
Abbott will receive 105 million shares of the combined company worth.
(Reporting by Shailesh Kuber; Editing by Sriraj Kalluvila)
BRIEF-International Paper agrees to settle Kleen products class action litigation
* International Paper agrees to settle kleen products class action litigation